Clinical Development, Regulatory, and Reimbursement Review Duration of New Drugs in the US and European Countries

JAMA Health Forum · Published 2026-07-24 · DOI 10.1001/jamahealthforum.2026.2332

Free full text

Authors (6)

Simon Hediger, Camille E.G. Glaus, Stacie B. Dusetzina, Ulrich-Peter Rohr, Thomas J. Hwang, Kerstin Noelle Vokinger

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Hediger, S., Glaus, C., Dusetzina, S., et al. (2026). Clinical Development, Regulatory, and Reimbursement Review Duration of New Drugs in the US and European Countries. JAMA Health Forum. https://doi.org/10.1001/jamahealthforum.2026.2332

Related articles

• JAMA Health Forum · JAMA Health Forum · 2026 · Same journal
• Error in Table 3 · JAMA Health Forum · 2026 · Same journal
• Medicaid Expansion and Mortality Among Formerly Incarcerated Individuals · JAMA Health Forum · 2026 · Same journal
• Making the FDA Great Again · JAMA Health Forum · 2026 · Same journal
• Losing Our Lens on Maternal and Infant Health—The Consequences of Disrupting PRAMS · JAMA Health Forum · 2026 · Same journal
• Product Reformulation in Response to the 2016 FDA Updated Nutrition Facts Label · JAMA Health Forum · 2026 · Same journal
• Ultralow-Volume Treatments for Mosquito-Borne Diseases · JAMA Health Forum · 2026 · Same journal
• State-Level Abortion Bans and the OBGYN Workforce · JAMA Health Forum · 2026 · Same journal
• Institutional Variation in Life-Sustaining Treatments and Mortality Among Older Patients · JAMA Health Forum · 2026 · Same journal
• Trends and Factors in Nursing Home Closures · JAMA Health Forum · 2026 · Same journal